Skip to main content
. 2009 Apr 28;11(2):250–261. doi: 10.1208/s12248-009-9102-7

Table VII.

Vss values from ex situ studies in rat

Interaction Transporter Organ Vss Change Prediction from Trends Reference
Digoxin+Rifampin Oatp1a4 uptake Liver ↓ 17.9% (68)
Quinapril+PAH Oat uptake Kidney ↓ 13.7%* ↔, (↓) (69)
Digoxin+Quinidine P-gp efflux Liver ↑ 95.9% (70)
Tacrolimus+GG918 P-gp efflux Liver ↑ 30.1% (70)
Talinolol+GG918 P-gp efflux Liver ↑ 74.2% (70)
Doxorubicin+GG918 P-gp efflux Liver ↑ 70.2%* (71)

Italicized interactions are those where the data does not match the prediction from the present analysis.

* indicates calculated parameters, not reported in reference

PAH: p-aminohippurate, GG918: GF120918 (Elacridar)